bioRxivBiochemistry
The TUDOR domain of SMN is an H3K79me1 histone mark reader
O. Binda, A. B. Kimenyi Ishimwe, M. Galloy, K. Jacquet, A. Corpet, A. Fradet-Turcotte, J. Cote, P. Lomonte
Abstract
Spinal Muscle Atrophy (SMA) is the leading genetic cause of infant mortality and results from the loss of functional Survival Motor Neuron (SMN) protein by either deletion or mutation of the SMN1 gene. SMN is characterized by a central TUDOR domain, which mediates the association of SMN with arginine methylated (Rme) partners, such as COILIN, FIBRILLARIN, and RNApolII. Herein, we biochemically demonstrate that SMN also associates with histone H3 monomethylated on lysine 79 (H3K79me1), defining SMN as the first known H3K79me1 histone mark reader, and thus the first histone mark reader to recognize both methylated arginine and lysine residues. Mutational analyzes provide evidence that SMNTUDOR associates with H3 via an aromatic cage. Importantly, most SMNTUDOR mutants found in SMA (SMNST) patients fail to associate with H3K79me1. Summary BlurbSpinal Muscle Atrophy (SMA) is caused by mutation or deletion of SMN1 gene. Survival Motor Neuron (SMN) protein associates with histone H3 mono-methylated on lysine 79 (H3K79me1) through its central TUDOR domain. SMA-linked mutations occur within the TUDOR domain and prevent association with histone H3.
- organism: human
- assay: ChIP-seq
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A small-molecule antagonist for the Tudor domain of SMN disrupts the interaction between SMN and RNAP II
- Temperature sensitive SMA-causing point mutations lead to SMN instability, locomotor defects, and premature lethality in Drosophila
Amanda C. Raimer, Suhana S. Singh, … A. Gregory Matera·Disease Models & MechanismsPeer-reviewed·Jan 1, 2020
- Pathological mutation in SMN impairs modulation of GAR1 phase separation linking condensate dysfunction to Spinal Muscular Atrophy
Sara S. Félix, Philip O’Toole, … Eurico J. Cabrita·bioRxiv·Jan 30, 2025
- SMN controls neuromuscular junction integrity through U7 snRNP
Sarah Tisdale, Meaghan Van Alstyne, … Livio Pellizzoni·Cell ReportsPeer-reviewed·Sep 1, 2022
- Self-oligomerization regulates stability of Survival Motor Neuron (SMN) protein isoforms by sequestering an SCFSlmb degron
K. M. Gray, K. A. Kaifer, … A. G. Matera·bioRxiv·Sep 30, 2016
- Towards a combined therapy for spinal muscular atrophy based on opposing effects of an antisense oligonucleotide on chromatin and splicing
Luciano E. Marasco, Gwendal Dujardin, … Alberto Rodolfo Kornblihtt·CellPeer-reviewed·Jun 1, 2022